MARGARITA SALA LLINÀS

Barreira-Díaz A, Riveiro-Barciela M, Fernández-Bonilla EM, Bernal V, Castiella A, Casado-Martín M, Delgado C, Londoño MC, Díaz-González Á, Pérez-Medrano I, Conthe A, Sala M, Mateos B, Gómez-Camarero J, Antón-Conejero D, Pozo-Calzada CD, Cuenca F, Villena AV, Salcedo M

Outcomes and factors associated with relapse of vaccine-induced liver injury after SARS CoV-2 immunization: A nationwide study

ANNALS OF HEPATOLOGY, 2024, 29, 101489-101489 dx.doi.org/10.1016/j.aohep.2024.101489

Enfermedades Digestivas y Microbiota

Diaz-Gonzalez, A, Ferreiro, E, Gómez-Domínguez, E, Caballero, A, Salcedo, M, Santos-Laso, A, Azaceta, MDB, Sousa-Martin, JM, Gómez-Camarero, J, Medrano, IP, Fernández-Rodríguez, C, Muñoz, BM, Almeida, AA, Barciela, MR, Esteban, P, VazRomero, I, Horta, D, Conde, I, Martínez, EI, Rodríguez-Perálvarez, ML, Cuerva, MO, Llinás, MS, García-Retortillo, M, Alsina, TH, Miquel, M, González, JM, Londoño, MC, Crespo, J

Incidence of fungal and other opportunistic infections in patients with autoimmune hepatitis: a spanish multicentre study

JOURNAL OF HEPATOLOGY, 2024, 80, 330-331

Enfermedades Digestivas y Microbiota

Azaceta, MDB, Llinás, MS, Horta, D, Esarte, SG, Gómez-Camarero, J, Guerra, MH, Majano, L, González, JM, González, JM, Herrojo, JA, Salcedo, M, Vergara, M, Salmerón, J, León, RR, García-Retortillo, M, Rodriguez-Tajes, S, Morillas, RM, Fernández-de la Varga, M, Castello, I, Lorente, S, Medrano, IP, Alarcon, FC, Conejero, MDA, Almeida, AA, Barciela, MR, Gómez-Domíguez, E, Blanco, S, Tejedor-Tejada, J, Alemany, MR, Linares, P, Herreros, AM, Andrade, RJ, Cancelo, AA, Crespo, J, Londoño, MC, Díaz-González, A

Diabetes mellitus (DM) is associated with worse outcomes in patients with primary biliary cholangitis (PBC) regardless of the presence of liver steatosis: results from the ColHai registry

JOURNAL OF HEPATOLOGY, 2024, 80, 329-330

Enfermedades Digestivas y Microbiota

Diaz-Gonzalez, A, Ferreiro, E, Gómez-Domínguez, E, Caballero, A, Salcedo, M, Santos-Laso, A, Azaceta, MD, González-Pascual, A, Sousa-Martin, JM, Gómez-Camarero, J, Medrano, IP, Fernández-Rodríguez, C, Muñoz, BM, Almeida, AA, Barciela, MR, Esteban, P, VazRomero, I, Horta, D, Conde, I, Martínez, IE, Rodríguez-Perálvarez, ML, Cuerva, MO, Llinas, MS, García-Retortillo, M, Alsina, TH, Miquel, M, Santiago, JMG, Londoño, MC, Crespo, J

Prophylaxis for tuberculosis and pneumocystis jirovecii does not seem necessary in patients with autoimmune hepatitis treated with corticosteroid therapy: spanish multicentre study

JOURNAL OF HEPATOLOGY, 2024, 80, 318-319

Enfermedades Digestivas y Microbiota

Sánchez, FMFG, Rodriguez-Tajes, S, Londoño, MC, Díaz-González, A, Llinás, MS, Romero-Gómez, M, González, JM, Gámez-Camarero, J, Guerra, MH, Vergara, M, Fournot, TS, Andrade, RJ, Esarte, SG, Vázquez, JT, García-Retortillo, M, Berenguer, M, Gómez-Domínguez, E

Optimization of treatment in patients with primary biliary cholangitis: Gamma-glutamyl transferase levels as an early prognostic marker for ursodeoxycholic acid response. Results from the ColHai registry

JOURNAL OF HEPATOLOGY, 2024, 80, 344-344

Enfermedades Digestivas y Microbiota

Hernàndez-Evole, H, Olivas, I, Manzorro, AG, Llinás, MS, Villagrasa, A, García-Retortillo, M, Sobenko, N, Muñoz, BM, Horta, D, Mezzano, G, Castello, I, Villamil, A, Salcedo, M, Londoño, MC, Rodriguez-Tajes, S

Paris II criteria are better than Poise to predict liver-related complications after second line therapy in patients with primary biliary cholangitis

JOURNAL OF HEPATOLOGY, 2024, 80, 336-336

Enfermedades Digestivas y Microbiota

Masnou H, Aguilar A, Iborra I, Sala M, Torner M, Clos-Parals A, Ardèvol A, Giménez M, Fortuny M, Sarrias MR, Morillas RM, Domènech E

Incidence, risk factors and clinical outcomes of multidrug-resistant microorganism infections among patients admitted for decompensated cirrhosis: A prospective study.

GASTROENTEROLOGIA Y HEPATOLOGIA, 2023, 46, 288-296 dx.doi.org/10.1016/j.gastrohep.2022.09.001

Enfermedades Digestivas y Microbiota

Muñoz-Martínez S, Sapena V, Forner A, Bruix J, Sanduzzi-Zamparelli M, Ríos J, Bouattour M, El Kassas M, Leal CRG, Mocan T, Nault JC, Alves RCP, Reeves HL, da Fonseca L, García-Juárez I, Pinato DJ, Varela M, Alqahtani SA, Alvares-da-Silva MR, Bandi JC, Rimassa L, Lozano M, González Santiago JM, Tacke F, Sala M, Anders M, Lachenmayer A, Piñero F, França A, Guarino M, Elvevi A, Cabibbo G, Peck-Radosavljevic M, Rojas Á, Vergara M, Braconi C, Pascual S, Perelló C, Mello V, Rodríguez-Lope C, Acevedo J, Villani R, Hollande C, Vilgrain V, Tawheed A, Ferguson Theodoro C, Sparchez Z, Blaise L, Viera-Alves DE, Watson R, Carrilho FJ, Moctezuma-Velázquez C, D'Alessio A, Iavarone M, Reig M

Outcome of liver cancer patients with SARS-CoV-2 infection: An International, Multicentre, Cohort Study

LIVER INTERNATIONAL, 2022, 42, 1891-1901 dx.doi.org/10.1111/liv.15320

Enfermedades Digestivas y Microbiota

Reig A, Álvarez-Navascués C, Vergara M, Gómez-Domínguez E, Gallego-Moya A, Pérez-Medrano IM, Fábrega E, Hernández-Guerra M, Berenguer M, Estevez P, Arencibia A, Morillas RM, Horta D, Albillos A, Casado M, De la Cruz G, Fernandez-Bonilla E, Molina E, Hijona L, Diago M, Fernández-Rodriguez CM, González-Santiago JM, Sala M, Gómez-Camarero J, Romero-Gomez M, Suárez F, Vargas V, Ferre-Aracil C, Andrade RJ, Chahri N, Parés A

Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116, 2250-2257 dx.doi.org/10.14309/ajg.0000000000001343

Enfermedades Digestivas y Microbiota

Muñoz-Martínez S, Sapena V, Forner A, Nault JC, Sapisochin G, Rimassa L, Sangro B, Bruix J, Sanduzzi-Zamparelli M, Holówko W, El Kassas M, Mocan T, Bouattour M, Merle P, Hoogwater FJH, Alqahtani SA, Reeves HL, Pinato DJ, Giorgakis E, Meyer T, Villadsen GE, Wege H, Salati M, Mínguez B, Di Costanzo GG, Roderburg C, Tacke F, Varela M, Galle PR, Alvares-da-Silva MR, Trojan J, Bridgewater J, Cabibbo G, Toso C, Lachenmayer A, Casadei-Gardini A, Toyoda H, Lüdde T, Villani R, Matilla Peña AM, Guedes Leal CR, Ronzoni M, Delgado M, Perelló C, Pascual S, Lledó JL, Argemi J, Basu B, da Fonseca L, Acevedo J, Siebenhüner AR, Braconi C, Meyers BM, Granito A, Sala M, Rodríguez-Lope C, Blaise L, Romero-Gómez M, Piñero F, Gomez D, Mello V, Pinheiro Alves RC, França A, Branco F, Brandi G, Pereira G, Coll S, Guarino M, Benítez C, Anders MM, Bandi JC, Vergara M, Calvo M, Peck-Radosavljevic M, García-Juárez I, Cardinale V, Lozano M, Gambato M, Okolicsanyi S, Morales-Arraez D, Elvevi A, Muñoz AE, Lué A, Iavarone M, Reig M

Assessing the impact of COVID-19 on liver cancer management (CERO-19)

JHEP REPORTS, 2021, 3, 100260-100260 dx.doi.org/10.1016/j.jhepr.2021.100260

Directori

Publicacions

Outcomes and factors associated with relapse of vaccine-induced liver injury after SARS CoV-2 immunization: A nationwide study

Incidence of fungal and other opportunistic infections in patients with autoimmune hepatitis: a spanish multicentre study

Diabetes mellitus (DM) is associated with worse outcomes in patients with primary biliary cholangitis (PBC) regardless of the presence of liver steatosis: results from the ColHai registry

Prophylaxis for tuberculosis and pneumocystis jirovecii does not seem necessary in patients with autoimmune hepatitis treated with corticosteroid therapy: spanish multicentre study

Optimization of treatment in patients with primary biliary cholangitis: Gamma-glutamyl transferase levels as an early prognostic marker for ursodeoxycholic acid response. Results from the ColHai registry

Paris II criteria are better than Poise to predict liver-related complications after second line therapy in patients with primary biliary cholangitis

Incidence, risk factors and clinical outcomes of multidrug-resistant microorganism infections among patients admitted for decompensated cirrhosis: A prospective study.

Outcome of liver cancer patients with SARS-CoV-2 infection: An International, Multicentre, Cohort Study

Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study

Assessing the impact of COVID-19 on liver cancer management (CERO-19)

Formulari de contacte

Conoce el IDIBGI!